BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24238383)

  • 1. Irreversible electroporation: ready for prime time?
    Lu DS; Kee ST; Lee EW
    Tech Vasc Interv Radiol; 2013 Dec; 16(4):277-86. PubMed ID: 24238383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "How we do it" - a practical approach to hepatic metastases ablation techniques.
    Sofocleous CT; Sideras P; Petre EN
    Tech Vasc Interv Radiol; 2013 Dec; 16(4):219-29. PubMed ID: 24238377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Niche Applications of Irreversible Electroporation.
    Bhatia SS; Arya R; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):170-5. PubMed ID: 26365547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible Electroporation for Colorectal Liver Metastases.
    Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor ablation: common modalities and general practices.
    Knavel EM; Brace CL
    Tech Vasc Interv Radiol; 2013 Dec; 16(4):192-200. PubMed ID: 24238374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to Irreversible Electroporation--Principles and Techniques.
    Thomson KR; Kavnoudias H; Neal RE
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):128-34. PubMed ID: 26365541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible Electroporation in the Treatment of Hepatocellular Carcinoma.
    Lencioni R; Crocetti L; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):135-9. PubMed ID: 26365542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Approach to Irreversible Electroporation of the Pancreas: Miami Protocol.
    Venkat S; Hosein PJ; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):153-8. PubMed ID: 26365545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tumor ablation techniques for cancer treatment (microwave, electroporation).
    de Baere T; Deschamps F
    Diagn Interv Imaging; 2014; 95(7-8):677-82. PubMed ID: 24818966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SI: Irreversible Electroporation (IRE). Introduction.
    Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):127. PubMed ID: 26365540
    [No Abstract]   [Full Text] [Related]  

  • 11. Image-guided thermal ablation of lung malignancies.
    Dupuy DE
    Radiology; 2011 Sep; 260(3):633-55. PubMed ID: 21846760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New techniques of tumor ablation (microwaves, electroporation)].
    de Baere T
    J Radiol; 2011 Sep; 92(9):789-95. PubMed ID: 21944237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible electroporation for the ablation of liver tumors: are we there yet?
    Charpentier KP
    Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging needle ablation technology in urology.
    Leveillee RJ; Pease K; Salas N
    Curr Opin Urol; 2014 Jan; 24(1):98-103. PubMed ID: 24247176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.
    Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR
    Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
    Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
    Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.
    Scheffer HJ; Nielsen K; de Jong MC; van Tilborg AA; Vieveen JM; Bouwman AR; Meijer S; van Kuijk C; van den Tol PM; Meijerink MR
    J Vasc Interv Radiol; 2014 Jul; 25(7):997-1011; quiz 1011. PubMed ID: 24656178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-guided fusion and navigation: applications in tumor ablation.
    Appelbaum L; Mahgerefteh SY; Sosna J; Goldberg SN
    Tech Vasc Interv Radiol; 2013 Dec; 16(4):287-95. PubMed ID: 24238384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal ablation of tumours: biological mechanisms and advances in therapy.
    Chu KF; Dupuy DE
    Nat Rev Cancer; 2014 Mar; 14(3):199-208. PubMed ID: 24561446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablative therapies: Advantages and disadvantages of radiofrequency, cryotherapy, microwave and electroporation methods, or how to choose the right method for an individual patient?
    Seror O
    Diagn Interv Imaging; 2015 Jun; 96(6):617-24. PubMed ID: 25981214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.